Literature DB >> 22735924

Suppression of lipopolysaccharide-induced upregulation of toll-like receptor 4 by emodin in mouse proximal tubular epithelial cells.

Xiao-Ling Zhu1, Yong-Jun Wang, Ya-Ζhen Yang, Ru-Chun Yang, Bin Zhu, Ying-Ηua Zhang, Yi Lin, Ying Lu, Xiao-Feng Li, Kevin T O'Byrne.   

Abstract

The aim of this study was to investigate the effects of emodin, the major component of Rheum palmatum, on lipopolysaccharide (LPS)-induced toll-like receptor 4 (TLR4) expression in cultured mouse tubular epithelial cells (TECs). The TECs were obtained from mice and incubated with LPS and/or indicated concentrations of emodin for 24 h. Cytokeratin, α-SMA and vimentin were detected using immunohistochemistry. The TLR4 protein level was detected by flow cytometry. TNFα and IL-6 protein levels were measured using an enzyme-linked immunosorbent assay (ELISA). mRNA expression of TLR4, TNFα and IL-6 was detected using a reverse-transcription polymerase chain reaction (RT-PCR). Results showed that a concentration of 102 ng/ml LPS significantly upregulated TLR4 mRNA and protein levels. TNFα and IL-6 mRNA and protein levels were also increased. Emodin (at doses of 40, 20 and 10 µM) was able to inhibit LPS-induced TLR4 protein synthesis in cultured TECs. However, TNFα and IL-6 protein expression was decreased in cells treated with emodin at concentrations of 40 and 20 µM. These results demonstrate that an elevated expression of inflammatory cytokines and TLR4 in cells stimulated with LPS, were simultaneously inhibited by emodin. Emodin is therefore able to inhibit the LPS-induced expression of TLR4 in order to downregulate TNFα and IL-6 synthesis in TECs, which may contribute to the protective effects of emodin in renal disease.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22735924     DOI: 10.3892/mmr.2012.960

Source DB:  PubMed          Journal:  Mol Med Rep        ISSN: 1791-2997            Impact factor:   2.952


  10 in total

1.  Effects of Niaoduqing Particles () on Delaying Progression of Renal Dysfunction: A Post-trial, Open-Label, Follow-up Study.

Authors:  Ying Zheng; Nian-Song Wang; Yu-Ning Liu; Li-Qun He; Gui-Hua Jian; Xu-Sheng Liu; Zhao-Hui Ni; Xiao-Hong Cheng; Hong-Li Lin; Wen-Hua Zhou; Ya-Ping Wang; Jing-Ai Fang; Ya-Ni He; Hong-Tao Yang; Li-Juan Zhao; Han-Lu Ding; Li-Hua Wang; Ren-Huan Yu; Wen-Ge Li; Zhi-Ming Ye; Wang Guo; Yong-Li Zhan; Hui-Juan Mao; Zhao Hu; Chen Yao; Guang-Yan Cai; Xiang-Mei Chen
Journal:  Chin J Integr Med       Date:  2018-11-22       Impact factor: 1.978

2.  Gene alterations in monocytes are pathogenic factors for immunoglobulin a nephropathy by bioinformatics analysis of microarray data.

Authors:  Yingbo Guo; Wenfeng Gao; Danyang Wang; Weijing Liu; Zhongjie Liu
Journal:  BMC Nephrol       Date:  2018-07-20       Impact factor: 2.388

3.  Emodin reactivated autophagy and alleviated inflammatory lung injury in mice with lethal endotoxemia.

Authors:  Yan Dong; Li Zhang; Yu Jiang; Jie Dai; Ling Tang; Gang Liu
Journal:  Exp Anim       Date:  2019-07-11

4.  Daeshiho-tang Attenuates Atherosclerosis by Regulating Cholesterol Metabolism and Inducing M2 Macrophage Polarization.

Authors:  Min-Young Song; Haneul Cho; Sora Lee; Kyung Hye Lee; Weon Kim
Journal:  Life (Basel)       Date:  2022-01-28

5.  Astragalus-Saffron-Rhubarb Mixture Delays the Progress of Diabetic Nephropathy in db/db Mice.

Authors:  Xiao-Chun Zhou; Yao-Jun Liang; Long Qin; Guo-Hua Wei; Jian-Qin Wang
Journal:  Diabetes Metab Syndr Obes       Date:  2021-12-01       Impact factor: 3.168

Review 6.  Promoting Plant-Based Therapies for Chronic Kidney Disease.

Authors:  Muhammad Ali Khan; Andrew J Kassianos; Wendy E Hoy; Ahm Khurshid Alam; Helen G Healy; Glenda C Gobe
Journal:  J Evid Based Integr Med       Date:  2022 Jan-Dec

Review 7.  The progress and prospect of natural components in rhubarb (Rheum ribes L.) in the treatment of renal fibrosis.

Authors:  Yangyang Wang; Fangwei Yu; Ao Li; Zijia He; Caiyan Qu; Caiying He; Xiao Ma; Huakui Zhan
Journal:  Front Pharmacol       Date:  2022-08-29       Impact factor: 5.988

Review 8.  Therapeutic use of traditional Chinese herbal medications for chronic kidney diseases.

Authors:  Yifei Zhong; Yueyi Deng; Yiping Chen; Peter Y Chuang; John Cijiang He
Journal:  Kidney Int       Date:  2013-07-17       Impact factor: 10.612

9.  Efficacy and Safety of Niaoduqing Particles for Delaying Moderate-to-severe Renal Dysfunction: A Randomized, Double-blind, Placebo-controlled, Multicenter Clinical Study.

Authors:  Ying Zheng; Guang-Yan Cai; Li-Qun He; Hong-Li Lin; Xiao-Hong Cheng; Nian-Song Wang; Gui-Hua Jian; Xu-Sheng Liu; Yu-Ning Liu; Zhao-Hui Ni; Jing-Ai Fang; Han-Lu Ding; Wang Guo; Ya-Ni He; Li-Hua Wang; Ya-Ping Wang; Hong-Tao Yang; Zhi-Ming Ye; Ren-Huan Yu; Li-Juan Zhao; Wen-Hua Zhou; Wen-Ge Li; Hui-Juan Mao; Yong-Li Zhan; Zhao Hu; Chen Yao; Ri-Bao Wei; Xiang-Mei Chen
Journal:  Chin Med J (Engl)       Date:  2017-10-20       Impact factor: 2.628

Review 10.  Application of Herbal Traditional Chinese Medicine in the Treatment of Acute Kidney Injury.

Authors:  Hai-Di Li; Xiao-Ming Meng; Cheng Huang; Lei Zhang; Xiong-Wen Lv; Jun Li
Journal:  Front Pharmacol       Date:  2019-04-18       Impact factor: 5.810

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.